Preexisting influenza-specific CD4+ T cells correlate with disease protection against influenza challenge in humans

Cited by (982)

Items 401–500 of 982

1. Impact of ageing on the response and repertoire of influenza virus-specific CD4 T cells
   Kathleen G. Lanzer, Lawrence L. Johnson, David L. Woodland, Marcia A. Blackman · 2014 · Immunity & Ageing
2. Current challenges: from the path of “original antigenic sin” towards the development of universal flu vaccines
   Asim Biswas, Alok K. Chakrabarti, Shanta Dutta · 2019 · International Reviews of Immunology
3. Influenza-Specific Lung-Resident Memory CD8+T Cells
   Stephanie van de Wall, Vladimer P. Badovinac, John T. Harty · 2020 · Cold Spring Harbor Perspectives in Biology
4. Advances in the development of universal influenza vaccines
   Sarah C. Gilbert · 2012 · Influenza and Other Respiratory Viruses
5. Adenoviral vectors as novel vaccines for influenza
   Lynda Coughlan, Caitlin E. Mullarkey, Sarah C. Gilbert · 2015 · Journal of Pharmacy and Pharmacology
6. Advances and challenges in the development and production of effective plant-based influenza vaccines
   Vidadi M. Yusibov, Natasha Kushnir, Stephen J. Streatfield · 2014 · Expert Review of Vaccines
7. Extensive T cell cross-reactivity between diverse seasonal influenza strains in the ferret model
   Adrian J. Reber, Nedzad Music, Jin Hyang Kim, Shane Gansebom, Jufu Chen, Ian A. York · 2018 · Scientific Reports
8. Heterosubtypic Protections against Human-Infecting Avian Influenza Viruses Correlate to Biased Cross-T-Cell Responses
   Min Zhao, Kefang Liu, Jiejian Luo, Shuguang Tan, Chuansong Quan, Shuijun Zhang, Yan Chai, Jianxun Qi, Yan Li, Yuhai Bi et al. · 2018 · mBio
9. Enhanced Neutralizing Antibody Titers and Th1 Polarization from a Novel Escherichia coli Derived Pandemic Influenza Vaccine
   David A. G. Skibinski, Brendon John Hanson, Yu-Fang Lin, Veronika von Messling, Andrea Jegerlehner, Jason Boon Sern Tee, De Hoe Chye, Steven K. K. Wong, Amanda A. P. Ng, Hui Yin Lee et al. · 2013 · PLoS ONE
10. Longevity and Determinants of Protective Humoral Immunity After Pandemic Influenza Infection
    Saranya Sridhar, Shaima Begom, Katja Höschler, Alison Bermingham, Walt E. Adamson, William F. Carman, Steven Riley, Ajit Lalvani · 2014 · American Journal of Respiratory and Critical Care Medicine
11. Prolonged Evolution of Virus-Specific Memory T Cell Immunity after Severe Avian Influenza A (H7N9) Virus Infection
    Min Jie Zhao, Junbo Chen, Shuguang Tan, Tao Dong, Hui Jiang, Jiandong Zheng, Chuansong Quan, Qiaohong Liao, Hangjie Zhang, Xiling Wang et al. · 2018 · Journal of Virology
12. Cry Protein Crystals: A Novel Platform for Protein Delivery
    Manoj S. Nair, Marianne M. Lee, Astrid Bonnegarde-Bernard, Julie A. Wallace, Donald H. Dean, Michael C. Ostrowski, Richard W. Burry, Prosper N. Boyaka, Michael K. Chan · 2015 · PLoS ONE
13. Matrix MTMadjuvanted virosomal H5N1 vaccine induces balanced Th1/Th2 CD4+T cell responses in man
    Gabriel Kristian Pedersen, Haakon Sjursen, Jane Kristin Nøstbakken, Åsne Jul‐Larsen, Katja Höschler, Rebecca Jane Cox · 2014 · Human Vaccines & Immunotherapeutics
14. Seroprevalence of Influenza A(H1N1)pdm09 Virus Antibody, England, 2010 and 2011
    Katja Höschler, Catherine Thompson, Nick J Andrews, Mónica Galiano, Richard G. Pebody, Joanna Ellis, Elaine Stanford, Marc Baguelin, Elizabeth Miller, Maria Cristina Fleischmann Alves Zambon · 2012 · Emerging infectious diseases
15. Influenza Vaccines: A Moving Interdisciplinary Field
    Michael Schotsaert, Adolfo García‐Sastre · 2014 · Viruses
16. Dendritic cell NLRC4 regulates influenza A virus–specific CD4+ T cell responses through FasL expression
    Emma E. Hornick, Jargalsaikhan Dagvadorj, Zeb Ralph Zacharias, Ann M. Miller, Ryan Andrew Langlois, Peter Chen, Kevin L. Legge, Gail Abendroth Bishop, Fayyaz Shiraz Sutterwala, Suzanne L. Cassel · 2019 · Journal of Clinical Investigation
17. CD4+ T Cells Recognize Conserved Influenza A Epitopes through Shared Patterns of V-Gene Usage and Complementary Biochemical Features
    Alexander Greenshields‐Watson, Meriem Attaf, Bruce J. MacLachlan, Thomas Whalley, Cristina Rius, Aaron Wall, Angharad Lloyd, Hywel Hughes, Kathryn E. Strange, Georgina H. Mason et al. · 2020 · Cell Reports
18. Randomized, Double-Blind, Reference-Controlled, Phase 2a Study Evaluating the Immunogenicity and Safety of OVX836, A Nucleoprotein-Based Influenza Vaccine
    Isabel Leroux‐Roels, Gwenn Waerlop, Jessika Tourneur, Fien De Boever, Catherine Maes, Jacques Bruhwyler, Delphine Guyon-Gellin, Philippe Moris, Judith Mónica del Campo, Paul Willems et al. · 2022 · Frontiers in Immunology
19. Intranasal Introduction of Fc-Fused Interleukin-7 Provides Long-Lasting Prophylaxis against Lethal Influenza Virus Infection
    Moon Cheol Kang, Donghoon Choi, Young Woo Choi, Seong Jeong Park, Hong Namkoong, Ki Seok Park, So-Shin Ahn, Charles D. Surh, Sun‐Woo Yoon, Doo‐Jin Kim et al. · 2015 · Journal of Virology
20. Many Th Cell Subsets Have Fas Ligand–Dependent Cytotoxic Potential
    Dmitri Ivanovich Kotov, Jessica Amy Kotov, Michael F. Goldberg, Marc K. Jenkins · 2018 · The Journal of Immunology
21. Baseline immune profile by CyTOF can predict response to an investigational adjuvanted vaccine in elderly adults
    Christine Lingblom, Sangeeta Kowli, Nithya Swaminathan, Holden Terry Maecker, Stacie L. Lambert · 2018 · Journal of Translational Medicine
22. Targeting resident memory T cell immunity culminates in pulmonary and systemic protection against Brucella infection
    Hongbin Wang, Carol A. Hoffman, Xinghong Yang, Beata Clapp, David W. Pascual · 2020 · PLoS Pathogens
23. Prospects and Challenges in the Development of Universal Influenza Vaccines
    Anders Madsen, Rebecca Jane Cox · 2020 · Vaccines
24. Distinct Patterns of B-Cell Activation and Priming by Natural Influenza Virus Infection Versus Inactivated Influenza Vaccination
    Xiao-Song He, Tyson H. Holmes, Mrinmoy Sanyal, Randy A. Albrecht, Adolfo García‐Sastre, Cornelia L. Dekker, Mark M. Davis, Harry B. Greenberg · 2014 · The Journal of Infectious Diseases
25. Cross-immunity Against Avian Influenza A(H7N9) Virus in the Healthy Population Is Affected by Antigenicity-Dependent Substitutions
    William J. Liu, Shuguang Tan, Min Zhao, Chuansong Quan, Yuhai Bi, Ying Wu, Shuijun Zhang, Haifeng Zhang, Haixia Xiao, Jianxun Qi et al. · 2016 · The Journal of Infectious Diseases
26. High-dose influenza vaccine favors acute plasmablast responses rather than long-term cellular responses
    Jin Hyang Kim, H. Keipp Talbot, Margarita Mishina, Yuwei Zhu, Jufu Chen, Weiping Cao, Adrian J. Reber, Marie R. Griffin, David K. Shay, Sarah Spencer et al. · 2016 · Vaccine
27. Long-term maintenance of the influenza-specific cross-reactive memory CD4+ T-cell responses following repeated annual influenza vaccination
    Mai-Chi Trieu, Fan Zhou, Sarah Larteley Lartey, Åsne Jul‐Larsen, Siri Mjaaland, Saranya Sridhar, Rebecca Jane Cox · 2016 · The Journal of Infectious Diseases
28. Vaccine-Induced Boosting of Influenza Virus-Specific CD4 T Cells in Younger and Aged Humans
    Dolfi, Douglas V., Mansfield, Kathleen D., Kurupati, Raj K., Kannan, Senthil, Doyle, Susan A., Ertl, Hildegund C. J., Schmader, Kenneth E., Wherry, E. John · 2013 · PLoS ONE
29. Engineered probiotic Escherichia coli elicits immediate and long-term protection against influenza A virus in mice
    Ling Huang, Wei Tang, Lina He, Mengke Li, Lin Xian, Ao Hu, Xindi Huang, Zhouyu Wu, Zhiyong Wu, Shiyun Chen et al. · 2024 · Nature Communications
30. Protection against H5N1 Highly Pathogenic Avian and Pandemic (H1N1) 2009 Influenza Virus Infection in Cynomolgus Monkeys by an Inactivated H5N1 Whole Particle Vaccine
    Misako Nakayama, Shintaro Shichinohe, Yasushi Itoh, Hirohito Ishigaki, Mitsutaka Kitano, Masahiko Arikata, Van Loi Pham, Hideaki Ishida, Naoko Kitagawa, Masatoshi Okamatsu et al. · 2013 · PLoS ONE
31. Correlation between Virus Replication and Antibody Responses in Macaques following Infection with Pandemic Influenza A Virus
    Gerrit Koopman, Petra Mooij, Liesbeth Dekking, Daniëlla Mortier, Ivonne G. Nieuwenhuis, Melanie van Heteren, Harmjan Kuipers, Edmond J. Remarque, Katarina Radošević, Willy M J M Bogers · 2015 · Journal of Virology
32. Overarching Immunodominance Patterns and Substantial Diversity in Specificity and Functionality in the Circulating Human Influenza A and B Virus–Specific CD4+ T-Cell Repertoire
    Katherine A. Richards, John Jay Treanor, Jennifer Lynn Nayak, Andrea J. Sant · 2018 · The Journal of Infectious Diseases
33. Imprinting and Editing of the Human CD4 T Cell Response to Influenza Virus
    Sean A. Nelson, Andrea J. Sant · 2019 · Frontiers in Immunology
34. T Cell Epitope Discovery in the Context of Distinct and Unique Indigenous HLA Profiles
    Luca Hensen, Patricia T. Illing, Louise C. Rowntree, Jane Davies, Adrian Miller, Steven Y. C. Tong, Jennifer R. Habel, Carolien E. van de Sandt, Katie L. Flanagan, Anthony Wayne Purcell et al. · 2022 · Frontiers in Immunology
35. Cytotoxic CD4+ T cells driven by T-cell intrinsic IL-18R/MyD88 signaling predominantly infiltrate Trypanosoma cruzi-infected hearts
    Carlos Henrique Barbosa, Fábio B. Canto, Ariel Gomes, Layza Mendes Brandão, Jéssica R. Lima, Guilherme A. Melo, Alessandra Granato, Eula G. A. Neves, Walderez O. Dutra, Ana Carolina Oliveira et al. · 2022 · eLife
36. Influence of Microbiota on Vaccine Effectiveness: “Is the Microbiota the Key to Vaccine-induced Responses?”
    So‐Hee Hong · 2023 · The Journal of Microbiology
37. SARS-CoV-2: Immunity, Challenges with Current Vaccines, and a Novel Perspective on Mucosal Vaccines
    Raju Sunagar, Amit Singh, Sudeep Kumar · 2023 · Vaccines
38. Immunogenicity, safety, and preliminary efficacy evaluation of OVX836, a nucleoprotein-based universal influenza A vaccine candidate: a randomised, double-blind, placebo-controlled, phase 2a trial
    Isabel Leroux‐Roels, Paul Willems, Gwenn Waerlop, Yorick Janssens, Jessika Tourneur, Fien De Boever, Jacques Bruhwyler, Azhar Alhatemi, Bart Jacobs, Florence Nicolas et al. · 2023 · The Lancet Infectious Diseases
39. Serial influenza-vaccination reveals impaired maintenance of specific T-cell memory in patients with end-stage renal failure
    Urban Sester, Tina Schmidt, Martin K. Kuhlmann, Barbara Christine Gärtner, Heike Uhlmann‐Schiffler, Martina Sester · 2013 · Vaccine
40. Dynamics of Influenza Virus and Human Host Interactions During Infection and Replication Cycle
    Alex Madrahimov, Tomáš Helikar, Bryan Kowal, Guoqing Lu, Jim A. Rogers · 2012 · Bulletin of Mathematical Biology
41. Influenza Vaccination in Patients with Common Variable Immunodeficiency (CVID)
    Jan Florian Mieves, Kirsten Wittke, Helma Freitag, Hans‐Dieter Volk, Carmen Scheibenbogen, Leif G. Hanitsch · 2017 · Current Allergy and Asthma Reports
42. Immunogenicity of Influenza Vaccines: Evidence for Differential Effect of Secondary Vaccination on Humoral and Cellular Immunity
    Sietske K. Rosendahl Huber, Marion Hendriks, Ronald H. J. Jacobi, Jan van de Kassteele, Jolanda C. Mandersloot-Oskam, Renée A. J. van Boxtel, A. M. J. Wensing, Nynke Y. Rots, Willem Luytjes, Josine van Beek · 2019 · Frontiers in Immunology
43. Targets of influenza human T-cell response are mostly conserved in H5N1
    John Sidney, A-Reum Kim, Rory D. de Vries, Bjoern Peters, Philip S. Meade, Florian Krammer, Alba Grifoni, Alessandro Sette · 2024 · mBio
44. Immunologic Characterization of a Rhesus Macaque H1N1 Challenge Model for Candidate Influenza Virus Vaccine Assessment
    Jason A. Skinner, Sandra Zurawski, Chie Sugimoto, Heather Vinet-Oliphant, Parvathi Vinod, Yaming Xue, Kasi Russell‐Lodrigue, Randy A. Albrecht, Adolfo García‐Sastre, Andres Μ. Salazar et al. · 2014 · Clinical and Vaccine Immunology
45. Sequential Immunization with Universal Live Attenuated Influenza Vaccine Candidates Protects Ferrets against a High-Dose Heterologous Virus Challenge
    Irina Isakova–Sivak, Victoria Matyushenko, Tatiana S. Kotomina, Irina Kiseleva, Elena V. Krutikova, Svetlana Donina, Andrey R. Rekstin, Natalie V. Larionova, Daria А. Mezhenskaya, К. В. Сивак et al. · 2019 · Vaccines
46. Safety and Immunogenicity of a Novel Intranasal Influenza Vaccine (NasoVAX): A Phase 2 Randomized, Controlled Trial
    Sybil A. Tasker, Anna Wight O’Rourke, Anvar Suyundikov, Peta-Gay Jackson-Booth, Stephan Bart, Vyjayanthi Krishnan, Jianfeng Zhang, Katie J. Anderson, Bertrand Georges, M. Scot Roberts · 2021 · Vaccines
47. High-Dose Influenza Vaccine Is Associated With Reduced Mortality Among Older Adults With Breakthrough Influenza Even When There Is Poor Vaccine-Strain Match
    Sandra S. Chaves, Sarah Naeger, Kahina Lounaci, Yue Zuo, Matthew M. Loiacono, Quentin Pilard, Joshua Nealon, Marie Genin, Cédric Mahé · 2023 · Clinical Infectious Diseases
48. Nucleoprotein as a Promising Antigen for Broadly Protective Influenza Vaccines
    Alexandra Ya. Rak, Исакова-Сивак Ирина Николаевна, Руденко Лариса Георгиевна · 2023 · Vaccines
49. The Ongoing Battle Against Influenza: The challenge of flu transmission
    Seema S. Lakdawala, Kanta Subbarao · 2012 · Nature Medicine
50. Estimating influenza vaccine effectiveness: Evolution of methods to better understand effects of confounding in older adults
    Janet E. McElhaney, Melissa Kathryn Andrew, Shelly McNeil · 2017 · Vaccine
51. Tissue-resident memory T cells in protective immunity to influenza virus
    Seung‐Woo Lee, Karen Yeung, Tania H. Watts · 2024 · Current Opinion in Virology
52. Optimising vaccine immunogenicity in ageing populations: key strategies
    Guangzhen Jiang, Yushu Zou, Dongyu Zhao, Jingyou Yu · 2024 · The Lancet Infectious Diseases
53. Cohort Profile: The Flu Watch Study
    Ellen Fragaszy, Charlotte Warren‐Gash, Lili Wang, Andrew J Copas, Oliver Dukes, W. John Edmunds, Nilu P Goonetilleke, Gabrielle Harvey, Anne M. Johnson, Jana Kovar et al. · 2016 · International Journal of Epidemiology
54. Kinetics and Phenotype of the CD4 T Cell Response to Influenza Virus Infections
    Emma E. Hornick, Zeb Ralph Zacharias, Kevin L. Legge · 2019 · Frontiers in Immunology
55. The Cellular and Molecular Bases of Allergy, Inflammation and Tissue Fibrosis in Patients with IgG4-related Disease
    Song‐Chou Hsieh, Chieh‐Yu Shen, Hsien‐Tzung Liao, Ming‐Han Chen, Cheng-Han Wu, Ko‐Jen Li, Cheng-Shiun Lu, Yu‐Min Kuo, Hung‐Cheng Tsai, Chang‐Youh Tsai et al. · 2020 · International Journal of Molecular Sciences
56. Highly Sensitive Flow Cytometry Allows Monitoring of Changes in Circulating Immune Cells in Blood After Tdap Booster Vaccination
    Annieck M. Diks, Indu Khatri, Liesbeth E.M. Oosten, Bas de Mooij, Rick J. Groenland, Cristina Teodósio, Martín Pérez‐Andrés, Alberto Órfão, Guy A. M. Berbers, Jaap Jan Zwaginga et al. · 2021 · Frontiers in Immunology
57. Cellular Immunity Is Critical for Assessing COVID-19 Vaccine Effectiveness in Immunocompromised Individuals
    Eustache Paramithiotis, Scott Sugden, Eszter Papp, Marie Bonhomme, Todd Chermak, Stephanie Y. Crawford, Stefanie Z. Demetriades, Gerson Galdos, Bruce L. Lambert, John E. Mattison et al. · 2022 · Frontiers in Immunology
58. The Awesome Power of Human Genetics of Infectious Disease
    Kyle D. Gibbs, Benjamin H. Schott, Dennis C. Ko · 2022 · Annual Review of Genetics
59. Increase in IFNγ−IL-2+ Cells in Recent Human CD4 T Cell Responses to 2009 Pandemic H1N1 Influenza
    Jason M. Weaver, Hongmei Yang, David Roumanes, F. Eun-Hyung Lee, Hulin Wu, John Jay Treanor, Tim R. Mosmann · 2013 · PLoS ONE
60. Local memory CD4 T cell niches in respiratory viral infection
    Kurt B. Pruner, Marion Pepper · 2021 · The Journal of Experimental Medicine
61. Comparing Humoral and Cellular Immune Response Against HBV Vaccine in Kidney Transplant Patients
    P. Friedrich, Arne Sattler, K. Müller, Mikalai Nienen, Petra Reinke, Nina Babel · 2015 · American Journal of Transplantation
62. Extracellular vesicle-based vaccine platform displaying native viral envelope proteins elicits a robust anti-SARS-CoV-2 response in mice
    Katarzyna Polak, N. Greze, Maëlle Lachat, Delphine Merle, Steve Chiumento, Christelle Bertrand‐Gaday, Bernadette Trentin, Robert Z. Mamoun · 2020 · bioRxiv (Cold Spring Harbor Laboratory)
63. Understanding Immunity in Children Vaccinated With Live Attenuated Influenza Vaccine
    Ian Shannon, Chantelle L. White, Jennifer Lynn Nayak · 2019 · Journal of the Pediatric Infectious Diseases Society
64. Cellular Immune Response after Vaccination in Patients with Cancer—Review on Past and Present Experiences
    Maria Madeleine Rüthrich, Nicola Giesen, Sibylle C. Mellinghoff, Christina Theresa Rieger, Marie von Lilienfeld‐Toal · 2022 · Vaccines
65. The emergence of H7N9 viruses: a chance to redefine correlates of protection for influenza virus vaccines
    Florian Krammer, Rebecca Jane Cox · 2013 · Expert Review of Vaccines
66. Gold Nanoparticles (AuNPs): A New Frontier in Vaccine Delivery
    Joseph D. Comber, Anil K Bamezai · 2015 · Journal of Nanomedicine & Biotherapeutic Discovery
67. Seasonal Influenza Split Vaccines Confer Partial Cross-Protection against Heterologous Influenza Virus in Ferrets When Combined with the CAF01 Adjuvant
    Dennis Christensen, Jan Pravsgaard Christensen, Karen Smith Korsholm, Louise Krag Isling, Karin Erneholm, Allan Randrup Thomsen, Peter Lawætz Andersen · 2018 · Frontiers in Immunology
68. Heterosubtypic cross-protection correlates with cross-reactive interferon-gamma-secreting lymphocytes in the ferret model of influenza
    Karen E. Gooch, Anthony C. Marriott, Kathryn A. Ryan, Paul Yeates, Gillian S. Slack, Phillip J. Brown, Ross Fothergill, Catherine J. Whittaker, Miles W. Carroll · 2019 · Scientific Reports
69. T-Cell Immune Responses to SARS-CoV-2 Infection and Vaccination
    Samuele Notarbartolo · 2024 · Vaccines
70. Immune Responses in Acute and Convalescent Patients with Mild, Moderate and Severe Disease during the 2009 Influenza Pandemic in Norway
    Kristin Greve-Isdahl Mohn, Rebecca Jane Cox, Gro Tunheim, Jan‐Erik Berdal, Anna Germundsson Hauge, Åsne Jul‐Larsen, Norwegian Pandemic Group, Bjoern Peters, Fredrik Oftung, Christine Monceyron Jonassen et al. · 2015 · PLoS ONE
71. Novel Viral Vectored Vaccines for the Prevention of Influenza
    Teresa Lambe · 2012 · Molecular Medicine
72. Effective control of early Zika virus replication by Dengue immunity is associated to the length of time between the 2 infections but not mediated by antibodies
    Crisanta Serrano-Collazo, Erick X. Pérez-Guzmán, Petraleigh Pantoja, Mariah Hassert, Idia V. Rodríguez, Luis David Giavedoni, Vida L Hodara, Laura M. Parodi, Lorna A. Cruz, Teresa Arana et al. · 2020 · PLoS neglected tropical diseases
73. Inactivated influenza vaccine formulated with single-stranded RNA-based adjuvant confers mucosal immunity and cross-protection against influenza virus infection
    Yun‐Hee Kim, Yoo‐Jin Bang, Hyo‐Jung Park, Hae Li Ko, Sang‐In Park, Kyung-Ah Hwang, Hun Kim, Jae‐Hwan Nam · 2020 · Vaccine
74. The role of T‐cell immunity in COVID‐19 severity amongst people living with type II diabetes
    Zhen Wei Marcus Tong, Emma J. Grant, Stéphanie Gras, Melanie Wu, Corey Smith, Helen L. Barrett, Linda A. Gallo, Kirsty Renfree Short · 2021 · FEBS Journal
75. DAMPs and influenza virus infection in ageing
    Ramar Perumal Samy, Lina H. K. Lim · 2015 · Ageing Research Reviews
76. Clinical validation of IFNγ/IL-10 and IFNγ/IL-2 FluoroSpot assays for the detection of Tr1 T cells and influenza vaccine monitoring in humans
    Anne Chauvat, Nadine Benhamouda, Alain Gey, Francois Michel Lemoine, Staffan Paulie, Fabrice Carrat, Marie‐Lise Gougeon, Flore Rozenberg, Anne Krivine, Mustapha Cheraï et al. · 2013 · Human Vaccines & Immunotherapeutics
77. Effect of Immunosuppression on T-Helper 2 and B-Cell Responses to Influenza Vaccination
    Adrian Egli, Atul Humar, Lukas Andreas Widmer, Luiz F. Lisboa, Deanna M. Santer, Nicolas Johannes Mueller, Jörg Stelling, Aliyah Baluch, Daire O’Shea, Michael Houghton et al. · 2015 · The Journal of Infectious Diseases
78. Harnessing Local Immunity for an Effective Universal Swine Influenza Vaccine
    Elma Z. Tchilian, Barbara Holzer · 2017 · Viruses
79. Development of an adjuvanted nanoparticle vaccine against influenza virus, an in vitro study
    Kamonthip Rungrojcharoenkit, Panya Sunintaboon, Damon W. Ellison, Louis R. Macareo, Panuwat Midoeng, Preamrudee Chaisuwirat, Stefan Fernandez, Sukathida Ubol · 2020 · PLoS ONE
80. Flu Universal Vaccines: New Tricks on an Old Virus
    Ruikun Du, Qinghua Cui, Lijun Rong · 2020 · Virologica Sinica
81. Latent CMV Infection Is Associated With Lower Influenza Virus-Specific Memory T-Cell Frequencies, but Not With an Impaired T-Cell Response to Acute Influenza Virus Infection
    Sara P. H. van den Berg, Josien Lanfermeijer, Ronald H. J. Jacobi, Marion Hendriks, Martijn W. Vos, Roos van Schuijlenburg, Nening M. Nanlohy, José A. M. Borghans, Josine van Beek, Debbie van Baarle et al. · 2021 · Frontiers in Immunology
82. Characterizing the cellular and molecular variabilities of peripheral immune cells in healthy recipients of BBIBP-CorV inactivated SARS-CoV-2 vaccine by single-cell RNA sequencing
    Tong, Renyang, Luo, Lingjie, Zhao, Yichao, Sun, Mingze, Li, Ronghong, Zhong, Jianmei, Chen, Yifan, Hu, Liuhua, Li, Zheng, Shi, Jianfeng et al. · 2023 · Emerging Microbes & Infections
83. Aging and CMV Infection Affect Pre-existing SARS-CoV-2-Reactive CD8+ T Cells in Unexposed Individuals
    Norihide Jo, Rui Zhang, Hideki Ueno, Takuya Yamamoto, Daniela Weiskopf, Miki Nagao, Shinya Yamanaka, Yoko Hamazaki · 2021 · Frontiers in Aging
84. Exposed seronegative: Cellular immune responses to SARS-CoV-2 in the absence of seroconversion
    Cecilia Jay, Jeremy D. Ratcliff, Lance C. W. Turtle, Philip Goulder, Paul Klenerman · 2023 · Frontiers in Immunology
85. Immunization with matrix-, nucleoprotein and neuraminidase protects against H3N2 influenza challenge in pH1N1 pre-exposed pigs
    Eleni Vatzia, Katherine Feest, Adam McNee, Tanuja Manjegowda, Brigid Veronica Carr, Basudev Paudyal, Tiphany Chrun, Emmanuel Atangana Maze, Amy Mccarron, Susan Jane Morris et al. · 2023 · npj Vaccines
86. Longitudinal and Integrative Biomodeling of Effector and Memory Immune Compartments after Inactivated Influenza Vaccination
    Olivia Bonduelle, Nora Yahia, Sophie Sibéril, Nora Benhabilès, Fabrice Carrat, Anne Krivine, Flore Rozenberg, Jordan D. Dimitrov, Srini V. Kaveri, Angélique Curjol et al. · 2013 · The Journal of Immunology
87. Cytokine Diversity in the Th1-Dominated Human Anti-Influenza Response Caused by Variable Cytokine Expression by Th1 Cells, and a Minor Population of Uncommitted IL-2+IFNγ- Thpp Cells
    N. Deng, J. M. Weaver, T. Mosmann · 2014 · PLoS ONE
88. Immunodominant T-Cell Epitopes in the VP1 Capsid Protein of Rhinovirus Species A and C
    Cibele Marina Gaido, Shane Ramsay Stone, Abha Chopra, Wayne Robert Thomas, Peter Neils Le Souëf, Belinda J. Hales · 2016 · Journal of Virology
89. Direct IL-6 Signals Maximize Protective Secondary CD4 T Cell Responses against Influenza
    Tara M. Strutt, Karl Kai McKinstry, Yi Kuang, Caroline M. Finn, Ji Hae Hwang, Kunal Dhume, Stewart Sell, Susan L. Swain · 2016 · The Journal of Immunology
90. Novel Bivalent Viral-Vectored Vaccines Induce Potent Humoral and Cellular Immune Responses Conferring Protection against Stringent Influenza A Virus Challenge
    Claire Maria Tully, Senthil Kumar Chinnakannan, Caitlin E. Mullarkey, Marta Ulaszewska, Francesca Ferrara, Nigel James Temperton, Sarah C. Gilbert, Teresa Lambe · 2017 · The Journal of Immunology
91. Population Serologic Immunity to Human and Avian H2N2 Viruses in the United States and Hong Kong for Pandemic Risk Assessment
    Tara M Babu, Ranawaka A. P. M. Perera, Joseph Tsz Kei Wu, Theresa F. Fitzgerald, Carolyn Nolan, Benjamin John Cowling, Scott L. Krauss, John Jay Treanor, Malik J. S. Peiris · 2018 · The Journal of Infectious Diseases
92. Cellular immune response to human influenza viruses differs between H1N1 and H3N2 subtypes in the ferret lung
    Kathryn A. Ryan, Gillian S. Slack, Anthony C. Marriott, Jennifer A. Kane, Catherine J. Whittaker, Nigel J. Silman, Miles W. Carroll, Karen E. Gooch · 2018 · PLoS ONE
93. Differential influenza H1N1-specific humoral and cellular response kinetics in kidney transplant patients
    Vinay Rambal, Karin Müller, Chantip Dang‐Heine, Arne Sattler, Mikalai Dziubianau, Benjamin J. D. Weist, Si-Hong Luu, Alexandra Stoyanova, Peter Nickel, Andreas Thiel et al. · 2013 · Medical Microbiology and Immunology
94. Establishing long-lasting vaccine immunity: insights from mRNA and adjuvanted protein platforms
    Andrea-Clemencia Pineda-Peña, Kohei Hasegawa, Vincent Pavot, Catherine Berry, Béhazine Combadière, Guadalupe Cortés-Garcia, Adrian B. McDermott, Saranya Sridhar · 2025 · npj Vaccines
95. Impact of Pre-Existing Immunity to Influenza on Live-Attenuated Influenza Vaccine (LAIV) Immunogenicity
    Sreeja Biswas Roy, Clare M. Williams, Danushka K. Wijesundara, Yoichi Furuya · 2020 · Vaccines
96. Phenotypes and Functions of SARS-CoV-2-Reactive T Cells
    Min Kyung Jung, Eui‐Cheol Shin · 2021 · Molecules and Cells
97. Detecting signals of seasonal influenza severity through age dynamics
    Elizabeth C. Lee, Cecile G. Viboud, Lone Simonsen, Farid L. Khan, Shweta Bansal · 2015 · BMC Infectious Diseases
98. Degradable emulsion as vaccine adjuvant reshapes antigen-specific immunity and thereby ameliorates vaccine efficacy
    Chung‐Hsiung Huang, Chiung‐Yi Huang, Chih-Ping Cheng, Shih-Hsiung Dai, Hsin–Wei Chen, Chih‐Hsiang Leng, Pele Choi-Sing Chong, Shih‐Jen Liu, Ming‐Hsi Huang · 2016 · Scientific Reports
99. Quantitative profiling reveals minor changes of T cell receptor repertoire in response to subunit inactivated influenza vaccine
    Anastasiia L. Sycheva, Mikhail V. Pogorelyy, Ekaterina A. Komech, Anastasia A. Minervina, Ivan V. Zvyagin, Dmitriy B. Staroverov, Dmitriy M. Chudakov, Yuri B. Lebedev, Ilgar Z. Mamedov · 2018 · Vaccine
100. Needle-free delivery of influenza vaccine using the Med-Jet® H4 is efficient and elicits the same humoral and cellular responses as standard IM injection: A randomized trial
     Janna R. Shapiro, Breanna Hodgins, Hilary E. Hendin, Aakash Patel, Karim Menassa, Celine Menassa, Maurice Menassa, Jennifer A. Pereira, Brian J. Ward · 2019 · Vaccine